Artinia Considered Safe in Europe
The European Food Safety Authority...s (Parma, Italy) Panel on Dietetic Products, Nutrition, and Allergies (NDA Panel) has determined that Artinia, a chitin-glucan ingredient by Stratum Nutrition (St. Charles, MO), shall be considered safe for consumption under established terms in the European Union. In the NDA Panel opinion, the ingredient is referred to as KiOnutrime-CG, the brand name used by Stratum...s European partner KitoZyme (Herstal, Belgium).
The European Food Safety Authority...s (Parma, Italy) Panel on Dietetic Products, Nutrition, and Allergies (NDA Panel) has determined that Artinia, a chitin-glucan ingredient by Stratum Nutrition (St. Charles, MO), shall be considered safe for consumption under established terms in the European Union. In the NDA Panel opinion, the ingredient is referred to as KiOnutrime-CG, the brand name used by Stratum...s European partner KitoZyme (Herstal, Belgium).
Stratum expects official approval from the European Commission by October 2010.
Artinia is a natural, fungal chitin-glucan intended for cardiovascular support. Increasing daily fiber intake with soluble and insoluble fibers, Artinia 'supports the body...s natural defenses against oxidized-LDL (low-density lipoprotein) cholesterol,'ÃÂ says the company.
The ingredient can now be marketed as a powder-form food supplement in various applications including gelatin capsules and tablets.
The company states that a 12-week animal and a 30-day human pilot study with Artinia have shown beneficial results for arterial and heart health. The intended intake of chitin-glucan is two to five grams per day.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
